Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. , today announced the publication of positive results from a pivotal Phase 3 trial evaluating its investigational single-dose, ...

Scientists found that nanopores’ electrical charges control how ions flow and when pores temporarily shut down. The discovery could allow engineers to design nanopores that “learn” like synapses for ...